• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Onco360 Oncology Pharmacy

    News headline image
    Onco360® Has Been Selected as The National Specialty Pharmacy Partner for HYRNUO® (sevabertinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a Specialty Pharmacy Partner for PHYRAGO™ (dasatinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a Specialty Pharmacy Partner for INLURIYO™ (imlunestrant)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for QINLOCK® (ripretinib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc.
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for AVMAPKI™FAKZYNJA™ CO-PACK
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for GOMEKLI™ (mirdametinib), Manufactured By SpringWorks Therapeutics
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Vyloy® (zolbetuximab-clzb)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Revuforj® (revumenib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra® (tislelizumab-jsgr)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR Exon 19 Deletions or Exon 21 L858R Mutations
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO® (vorasidenib)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    CORRECTION -- Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360® Celebrates Excellent Patient Care, Reflected by Impressive Net Promoter Score
    From Onco360 Oncology Pharmacy
    Via GlobeNewswire
    News headline image
    Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)
    From Onco360 Oncology Pharmacy
    Via Business Wire
    News headline image
    FABHALTA (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
    From Onco360 Oncology Pharmacy
    Via Business Wire
    News headline image
    OGSIVEO™ (nirogacestat) Now Available from Onco360 as the First and Only FDA-Approved Treatment for Adults with Progressing Desmoid Tumors Who Require Systemic Treatment
    From Onco360 Oncology Pharmacy
    Via Business Wire
    News headline image
    TRUQAP™ (capivasertib) Now Available from Onco360
    From Onco360 Oncology Pharmacy
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.